-
-
Toggle navigation
Frontiers reaches 6.4 on Journal Impact Factors
in Medicine |
|
Submit your manuscript
Scope
Translational Medicine is innovation toward achieving the conversion of knowledge and research breakthroughs stemming from the bench into clinical practices with the ultimate goal of improving patient outcomes. Translational Medicine is achieved through cross-disciplinary interactions to overcome the traditional silos within the medical disciplines. Importantly, Translational Medicine emphasizes the partnership between basic life science researchers, engineers, clinical researchers, and clinical practitioners. While clinical research has been in the past observational, the advent of new diagnostic tools and technologies, has enabled the systematic, multiparameter monitoring of large patient cohorts and introduced the next phase of Translational Medicine, with clinical research leading to mechanistic discoveries; however, there are many challenges and road blocks on the way that must be addressed.
Read More
Scope
Translational Medicine is innovation toward achieving the conversion of knowledge and research breakthroughs stemming from the bench into clinical practices with the ultimate goal of improving patient outcomes. Translational Medicine is achieved through cross-disciplinary interactions to overcome the traditional silos within the medical disciplines. Importantly, Translational Medicine emphasizes the partnership between basic life science researchers, engineers, clinical researchers, and clinical practitioners. While clinical research has been in the past observational, the advent of new diagnostic tools and technologies, has enabled the systematic, multiparameter monitoring of large patient cohorts and introduced the next phase of Translational Medicine, with clinical research leading to mechanistic discoveries; however, there are many challenges and road blocks on the way that must be addressed.
The mission of this new section of Frontiers in Medicine on Translational Medicine, is to bring together the stakeholders of the field, as editors, reviewers and authors, to provide constructive feedback to one another with the goal of further enabling the translation of basic research findings and clinical observations into meaningful improvements in patient outcomes. This section publishes basic studies with direct clinical relevance, studies that compare results from animal models and clinical studies, as well as clinical trials and other observational studies with human samples. We also encourage the submission of articles addressing challenges in translation, such as standardization of preclinical studies and of biomarker developments, and GMP manufacturing. Policy papers that discuss the initiatives and environment needed to foster Translational Medicine is also considered for publication in this section. Of particular interest are the studies that integrate basic, translational and patient-oriented research as well as interdisciplinary studies that highlight innovations in the field.
Indexed in: PubMed, PubMed Central, Google Scholar, DOAJ, Emerging Sources Citation Index, CLOCKSS
PMCID: all published articles receive a PMCID
Translational Medicine welcomes submissions of the following article types: Addendum, Brief Research Report, Case Report, Clinical Study Protocol, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Protocols, Review, Specialty Grand Challenge, Systematic Review and Technology Report.
All manuscripts must be submitted directly to the section Translational Medicine, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Translational Medicine will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Medicine.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01